Literature DB >> 34893079

Genomic adaptations of Campylobacter jejuni to long-term human colonization.

Samuel J Bloomfield1, Anne C Midwinter2,3, Patrick J Biggs2,3,4, Nigel P French3,5, Jonathan C Marshall2,3,4, David T S Hayman2,3,6, Philip E Carter7, Alison E Mather8,9, Ahmed Fayaz2,3, Craig Thornley10, David J Kelly11, Jackie Benschop2,3.   

Abstract

BACKGROUND: Campylobacter is a genus of bacteria that has been isolated from the gastrointestinal tract of humans and animals, and the environments they inhabit around the world. Campylobacter adapt to new environments by changes in their gene content and expression, but little is known about how they adapt to long-term human colonization. In this study, the genomes of 31 isolates from a New Zealand patient and 22 isolates from a United Kingdom patient belonging to Campylobacter jejuni sequence type 45 (ST45) were compared with 209 ST45 genomes from other sources to identify the mechanisms by which Campylobacter adapts to long-term human colonization. In addition, the New Zealand patient had their microbiota investigated using 16S rRNA metabarcoding, and their level of inflammation and immunosuppression analyzed using biochemical tests, to determine how Campylobacter adapts to a changing gastrointestinal tract.
RESULTS: There was some evidence that long-term colonization led to genome degradation, but more evidence that Campylobacter adapted through the accumulation of non-synonymous single nucleotide polymorphisms (SNPs) and frameshifts in genes involved in cell motility, signal transduction and the major outer membrane protein (MOMP). The New Zealand patient also displayed considerable variation in their microbiome, inflammation and immunosuppression over five months, and the Campylobacter collected from this patient could be divided into two subpopulations, the proportion of which correlated with the amount of gastrointestinal inflammation.
CONCLUSIONS: This study demonstrates how genomics, phylogenetics, 16S rRNA metabarcoding and biochemical markers can provide insight into how Campylobacter adapts to changing environments within human hosts. This study also demonstrates that long-term human colonization selects for changes in Campylobacter genes involved in cell motility, signal transduction and the MOMP; and that genetically distinct subpopulations of Campylobacter evolve to adapt to the changing gastrointestinal environment.
© 2021. The Author(s).

Entities:  

Keywords:  Campylobacter; Genomics; Host adaptation; Phylogenetics

Year:  2021        PMID: 34893079      PMCID: PMC8665580          DOI: 10.1186/s13099-021-00469-7

Source DB:  PubMed          Journal:  Gut Pathog        ISSN: 1757-4749            Impact factor:   4.181


  79 in total

1.  Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform.

Authors:  James J Kozich; Sarah L Westcott; Nielson T Baxter; Sarah K Highlander; Patrick D Schloss
Journal:  Appl Environ Microbiol       Date:  2013-06-21       Impact factor: 4.792

Review 2.  Macrolide resistance in Campylobacter jejuni and Campylobacter coli.

Authors:  Amera Gibreel; Diane E Taylor
Journal:  J Antimicrob Chemother       Date:  2006-05-30       Impact factor: 5.790

3.  Spatial epidemiology and natural population structure of Campylobacter jejuni colonizing a farmland ecosystem.

Authors:  Nigel French; Mishele Barrigas; Patrick Brown; Paulo Ribiero; Nicola Williams; Howard Leatherbarrow; Richard Birtles; Eric Bolton; Paul Fearnhead; Andrew Fox
Journal:  Environ Microbiol       Date:  2005-08       Impact factor: 5.491

4.  Beta-lactamase-mediated beta-lactam resistance in Campylobacter species: prevalence of Cj0299 (bla OXA-61) and evidence for a novel beta-Lactamase in C. jejuni.

Authors:  Deborah J Griggs; Leanne Peake; Margaret M Johnson; Saba Ghori; A Mott; Laura J V Piddock
Journal:  Antimicrob Agents Chemother       Date:  2009-06-08       Impact factor: 5.191

5.  Sensitivity and specificity of serology in determining recent acute Campylobacter infection.

Authors:  B V Taylor; J Williamson; J Luck; D Coleman; D Jones; A McGregor
Journal:  Intern Med J       Date:  2004-05       Impact factor: 2.048

6.  CheckM: assessing the quality of microbial genomes recovered from isolates, single cells, and metagenomes.

Authors:  Donovan H Parks; Michael Imelfort; Connor T Skennerton; Philip Hugenholtz; Gene W Tyson
Journal:  Genome Res       Date:  2015-05-14       Impact factor: 9.043

7.  Roary: rapid large-scale prokaryote pan genome analysis.

Authors:  Andrew J Page; Carla A Cummins; Martin Hunt; Vanessa K Wong; Sandra Reuter; Matthew T G Holden; Maria Fookes; Daniel Falush; Jacqueline A Keane; Julian Parkhill
Journal:  Bioinformatics       Date:  2015-07-20       Impact factor: 6.937

8.  Molecular Characterization and Meta-Analysis of Gut Microbial Communities Illustrate Enrichment of Prevotella and Megasphaera in Indian Subjects.

Authors:  Shrikant Bhute; Pranav Pande; Sudarshan A Shetty; Rahul Shelar; Sachin Mane; Shreyas V Kumbhare; Ashwini Gawali; Hemal Makhani; Mohit Navandar; Dhiraj Dhotre; Himangi Lubree; Dhiraj Agarwal; Rutuja Patil; Shantanu Ozarkar; Saroj Ghaskadbi; Chittaranjan Yajnik; Sanjay Juvekar; Govind K Makharia; Yogesh S Shouche
Journal:  Front Microbiol       Date:  2016-05-09       Impact factor: 5.640

9.  Succinate receptor mediates intestinal inflammation and fibrosis.

Authors:  Dulce C Macias-Ceja; Dolores Ortiz-Masiá; Sara Calatayud; María D Barrachina; Pedro Salvador; Laura Gisbert-Ferrándiz; Carlos Hernández; Martin Hausmann; Gerhard Rogler; Juan V Esplugues; Joaquín Hinojosa; Rafael Alós; Francisco Navarro; Jesus Cosin-Roger
Journal:  Mucosal Immunol       Date:  2018-10-02       Impact factor: 7.313

10.  Campylobacter genotypes from food animals, environmental sources and clinical disease in Scotland 2005/6.

Authors:  Samuel K Sheppard; John F Dallas; Marion MacRae; Noel D McCarthy; E L Sproston; F J Gormley; Norval J C Strachan; Iain D Ogden; Martin C J Maiden; Ken J Forbes
Journal:  Int J Food Microbiol       Date:  2009-02-20       Impact factor: 5.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.